Published October 21, 2019 | Version v1
Dataset Open

Purification of HTT aa. 76-3060 -HAP40 aa. 1-371 for structural analysis 2019/10/21

  • 1. Structural Genomics Consortium, University of Toronto


Project: Biophysical investigation of purified HTT protein samples

Experiment: Purification of HTT76-3060 -HAP401-371 from Sf9 

Date completed:­ 2019/10/21

Rationale: Purification of HTT76-3060 -HAP401-371 for structural analysis


Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.


Purification of HTT76-3060 -HAP401-371 for structural analysis 20191021.pdf